Try GOLD - Free
A miracle, but a miss
Business Standard
|July 10, 2025
Karnataka's rapid growth since 1991 hasn't translated into broader human development. It is time for a policy reset
Karnataka's transformation from being a state with per capita income 19 per cent below the national average in 1990-91 to becoming India's most vibrant technology and innovation hub, and a centre of the modern services industry, has been dramatic. From this lowly position, the state galloped to the second-highest rank among the large states, with per capita income higher than the country's average by 80 per cent in 2022-23.
This phenomenal growth was led predominantly by the services sector, contributing over 68 per cent of the value added—the highest among all the states. The per capita real income grew at an average rate of 6.4 per cent from 2011-12 to 2022-23, which was next only to that of Gujarat (6.8 per cent).
The liberalising reforms of 1991 unshackled entrepreneurship in the services sector more than in manufacturing, as there were fewer regulations. The capital city, Bengaluru, had the necessary ecosystem to seize this new-found freedom and emerge as a technology and innovation hub. With its concentration of scientific and technical institutions and a large pool of technical and scientific personnel, the transformation was only natural.
By 2023, Karnataka had 45 of India's 112 unicorns, accounting for 44.6 per cent of their total value, and hosted over 875 global capability centres (GCCs). In 2025, Bengaluru climbed seven spots to rank 14th in the Global Startup Ecosystem Index. It is the largest foreign investment destination and a leader in services exports. This is due to, inter alia, its impressive knowledge economy, skilled manpower, elite public institutions, salubrious climate, multicultural and cosmopolitan population and responsive bureaucracy.
With the large-scale migration of skilled personnel, the city transformed into a dynamic metropolis and a centre for scientific and technological innovation.
This story is from the July 10, 2025 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
